Skip to content

Citius Oncology, Inc. CTOR State income taxes – net of federal income tax benefit

State income taxes – net of federal income tax benefit at other companies

REX American Resources logo
REX American ResourcesREX
3.4%+0.2pp
Hitachi logo
HitachiHIT
3%-2.7pp
BCB Bancorp logo
BCB BancorpBCBP
6.4%-1.9pp
Norwood Financial logo
Norwood FinancialNWFL
0.1%+0.1pp
Bank7 Corp. logo
Bank7 Corp.BSVN
2.8%
Alto Ingredients, Inc. logo
Alto Ingredients, Inc.ALTO
1.3%-4.2pp

Other financials

Income statement

See full
Revenue$1.7M
Gross profit$1.3M
Operating income-$28.6M-283%
Net income-$26.6M-244%
EPS (diluted)-$0.27-145%

Balance sheet

See full
Cash & equivalents$2.6M+2,350,466%
Total equity$35.3M-1.0%
Total assets$100.7M+10.1%

Cash flow

See full
Operating cash flow-$3.8M-179%

Valuation

See full
Market cap$60.45M-74.7%

Returns & leverage

See full
Return on equity-119.9%+46.7pp
Current ratio0.5×+0.1×

Where this comes from

Reported directly by Citius Oncology, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes.

The official record: Citius Oncology, Inc.’s 10-K, filed December 23, 2025, on SEC EDGAR. View the filing →

Ask your AI about Citius Oncology, Inc.'s state income taxes – net of federal income tax benefit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Citius Oncology, Inc.'s state income taxes – net of federal income tax benefit?
Citius Oncology, Inc. (CTOR) reported state income taxes – net of federal income tax benefit of -21% in Q3 2025.
What does state income taxes – net of federal income tax benefit mean?
Reflects the impact of state and local tax jurisdictions on the company's overall effective tax rate. It highlights the geographic tax burden relative to the federal statutory rate.